View More View Less
  • 1 Gyógyszerésztudományi Kar, Farmakognóziai Intézet, Semmelweis Egyetem, Budapest, Üllői út 26., 1085

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1

    Zhu YP. Chinese materia medica. Chemistry, pharmacology and applications. CRC Press, Boca Raton FL, London, New York NY, Washigton DC, 1998.

  • 2

    Harada M, Ozaki Y. Pharmacological studies on Chinese cinnamon. I. Central effect of cinnamaldehyde. Yakugaku Zasshi 1972; 92: 135–140.

  • 3

    Lungarini S, Aureli F, Coni E. Coumarin and cinnamaldehyde in cinnamon marketed in Italy: a natural chemical hazard? Food Addit Contam. Part A. Chem Anal Control Expo Risk Assess 2008; 25: 1297–1305.

  • 4

    Tang W, Eisenbrand G. Handbook of Chinese medicinal plants, chemistry, pharmacology, toxicology. Wiley-VCH, Weinheim, 2011.

  • 5

    Yuan AX, Qin L, Jiang DG. Studies on the chemical constituents of Cinnamomum cassia. Chin Pharm Bull. 1981; 16: 631.

  • 6

    Wang YS. Pharmacology and applications of chinese materia medica. People’s Health Publisher, Beijing, 1983; pp. 442–446.

  • 7

    Yuan AX, Tan L, Jiang DG. Studies on chemical constituents of Rou Gui (Cinnamomum cassia Presl). Bull Chin Mater Med. 1982; 7: 26–28.

  • 8

    Tanaka S, Yoon YH, Fukui H, et al. Antiulcerogenic compounds isolated from Chinese cinnamon. Planta Med. 1989; 55: 245–248.

  • 9

    Ghosh P, Markin RS, Sorrell MF. Coumarin-induced hepatic necrosis. Am J Gastroenterol. 1997; 92: 348–349.

  • 10

    Kreydiyyeh SI, Usta J, Copti R. Effect of cinnamom, clove and some of their constituents on the Na+-K+-ATPase activity and alanine absorption in the rat jejunum. Food Chem Toxicol. 2000; 38: 755–762.

  • 11

    Cheng JT, Liu IM, Huang WC, et al. Stimulatory effect of trans-cinnamaldehyde on noradrenaline secretion in guinea-pig ileum myenteric nerve terminals. Life Sci. 2000; 66: 981–990.

  • 12

    Lee HS, Kim BS, Kim MK. Suppression effect of Cinnamomun cassia bark-derived component on nitric oxide synthase. J Agric Food Chem. 2002; 50: 7700–7703.

  • 13

    Lee HS, Lee SY, Son DJ, et al. Inhibitory effect of 2’-hydroxycinnamaldehyde on nitric oxide production through inhibition of NF-κB activation in RAW 264.7 cells. Biochem Pharmacol. 2005; 69: 791–799.

  • 14

    Sasaki YF, Ohta T, Imanishi H, et al. Suppressing effects of vanillin, cinnamaldehyde and anisaldehyde on chromosome abberations induced by X-rays in mice. Mutat Res. 1990; 243: 299–302.

  • 15

    Sasaki YF, Imanishi H, Watanabe M, et al. Suppressing effect of antimutagenic flavorings on chromosome aberrations induced by UV-light or X-rays in cultured Chinese hamster cells. Mutat Res. 1990; 229: 1–10.

  • 16

    Sharma N, Trikha P, Athar M, et al. Inhibition of benzo[a]pyrene- and cyclophosphamide-induced mutagenicity by Cinnamomun cassia. Mutat Res. 2001; 480-481: 189–188.

  • 17

    Liu L, Hudgins WR, Shack S, et al. Cinnamic acid: a natural product with potential use in cancer intervention. Int J Cancer 1995; 62: 345–350.

  • 18

    Stammati A, Bonsi P, Zucco F, et al. Toxicity of selected plant volatiles in microbial and mammalian short-term assays. Food Chem Toxicol. 1999; 37: 813–823.

  • 19

    Ekmekcioglu C, Feyertag J, Marktl W. Cinnamic acid inhibits proliferation and modulates brush border membrane enzyme activities in Caco-2 cells. Cancer Lett. 1998; 128: 137–144.

  • 20

    Gujral UP, Pradeepa R, Weber MB, et al. Type 2 diabetes in South Asians: Similarities and differences with white Caucasian and other populations. Ann NY Acad Sci. 2013; 1281: 51–63.

  • 21

    Anand SS, Meyre D, Pare G, et al. Genetic information and the prediction of incident type 2 diabetes in a high-risk multiethnic population: the EpiDREAM genetic study. Diabetes Care 2013; 36: 2836–2842.

  • 22

    Shah A, Kanaya AM. Diabetes and associated complications in the South Asian population. Curr Cardiol Rep. 2014; 16: 476.

  • 23

    Crawford P. Effectiveness of cinnamon for lowering hemoglobin A1c in patients with type 2 diabetes: a randomized, controlled trial. J Am Board Fam Med. 2009; 22: 507–512.

  • 24

    Blevins SM, Leyva MJ, Brown J, et al. Effect of cinnamon on glucose and lipid levels in non-insulin-dependent type 2 diabetes. Diabetes Care 2007; 30: 2236–2237.

  • 25

    Ranasinghe P, Jayawardana R, Galappaththy P, et. al. Efficacy and safety of “true” cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta-analysis. Diabet Med. 2012; 29: 1480–1492.

  • 26

    Cao H, Polansky MM, Anderson RA. Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes. Arch Biochem Biophys. 2007; 459: 214–222.

  • 27

    Imparl-Radosevich J, Deas S, Polansky MM, et al. Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signalling. Horm Res. 1998; 50: 177–182.

  • 28

    Jarvill-Taylor KJ, Anderson RA, Graves DJ. A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3–L1 adipocytes. J Am Coll Nutr. 2001; 20: 327–336.

  • 29

    Qin B, Nagasaki M, Ren M, et al. Cinnamon extract (traditional herb) potentiates in vivo insulin-regulated glucose utilization via enhancing insulin signaling in rats. Diabetes Res Clin Pract. 2003; 62: 139–148.

  • 30

    Sierra-Puente D, Abadi-Alfie S, Arakanchi-Altaled K, et al. Cinammon (Cinnamomum spp.) and type 2 diabetes mellitus. Curr Top Nutraceut Res. 2020; 18: 247–255.

  • 31

    Ranasinghe P, Galappaththy P, Constantine GR, et al. Cinnamomum zeylanicum (Ceylon cinnamon) as a potential pharmaceutical agent for type-2 diabetes mellitus: study protocol for a randomized controlled trial. Trials 2017; 18: 446.

  • 32

    Behbahani BA, Falah F, Arab FL, et al. Chemical composition and antioxidant, antimicrobial, and antiproliferative activities of Cinnamomum zeylanicum bark essential oil. Evid Based Complement Alternat Med. 2020; 2020: 5190603. https://doi.org/10.1155/2020/5190603

  • 33

    Lugasi A. Distribution of food supplements containing herbal active ingredients: legal environment, peer review. In: Blázovics A, Mézes M. (eds.) Natural active ingredients in modern medicine. [Növényi hatóanyagokat tartalmazó étrend-kiegészítők forgalmazása: jogi környezet, szakértői értékelés. In: Blázovics A, Mézes M. (szerk.) Természetes hatóanyagok a modern orvoslásban.] Szent István Egyetemi Kiadó Nonprofit Kft., Gödöllő, 2014; pp. 28–32. [Hungarian]

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Sep 2020 0 0 0
Oct 2020 0 0 0
Nov 2020 0 16 24
Dec 2020 0 94 63
Jan 2021 0 26 19
Feb 2021 0 26 22
Mar 2021 0 8 2